TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 334 filers reported holding TANDEM DIABETES CARE INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $334,342 | -48.4% | 8,233 | -42.9% | 0.01% | -50.0% |
| Q4 2022 | $647,909 | -0.5% | 14,414 | +6.0% | 0.01% | -23.1% |
| Q3 2022 | $651,000 | -18.8% | 13,600 | +0.4% | 0.01% | -18.8% |
| Q2 2022 | $802,000 | -46.7% | 13,546 | +4.8% | 0.02% | -36.0% |
| Q1 2022 | $1,504,000 | -24.1% | 12,930 | -1.8% | 0.02% | -19.4% |
| Q4 2021 | $1,982,000 | +30.1% | 13,170 | +3.1% | 0.03% | +6.9% |
| Q3 2021 | $1,524,000 | +130.9% | 12,770 | +88.5% | 0.03% | +141.7% |
| Q2 2021 | $660,000 | +32.0% | 6,774 | +19.5% | 0.01% | +9.1% |
| Q1 2021 | $500,000 | -5.1% | 5,668 | +2.9% | 0.01% | 0.0% |
| Q4 2020 | $527,000 | -15.7% | 5,507 | -0.1% | 0.01% | -26.7% |
| Q3 2020 | $625,000 | +17.5% | 5,510 | +2.5% | 0.02% | +7.1% |
| Q2 2020 | $532,000 | – | 5,375 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |